{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "REGULAR", "priceHint": 4, "regularMarketChange": 0.0045999885, "regularMarketTime": 1684255662, "regularMarketDayHigh": 0.5701, "regularMarketDayRange": "0.555 - 0.5701", "regularMarketDayLow": 0.555, "regularMarketVolume": 3893, "regularMarketPreviousClose": 0.5655, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 11, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.555, "averageDailyVolume3Month": 101041, "averageDailyVolume10Day": 53017, "fiftyTwoWeekLowChange": 0.2671, "fiftyTwoWeekLowChangePercent": 0.8815182, "fiftyTwoWeekRange": "0.303 - 0.58", "fiftyTwoWeekHighChange": -0.009899974, "fiftyTwoWeekHighChangePercent": -0.01706892, "fiftyTwoWeekLow": 0.303, "fiftyTwoWeekHigh": 0.58, "earningsTimestamp": 1668461880, "earningsTimestampStart": 1684234740, "earningsTimestampEnd": 1684670400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.01, "epsForward": -0.09, "epsCurrentYear": -0.54, "priceEpsCurrentYear": -1.0557407, "sharesOutstanding": 43832800, "bookValue": 0.871, "fiftyDayAverage": 0.5611932, "fiftyDayAverageChange": 0.008906782, "fiftyDayAverageChangePercent": 0.01587115, "twoHundredDayAverage": 0.48330694, "twoHundredDayAverageChange": 0.086793065, "twoHundredDayAverageChangePercent": 0.17958166, "marketCap": 24989080, "forwardPE": -6.3344445, "priceToBook": 0.65453506, "messageBoardId": "finmb_291066188", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketPrice": 0.5701, "exchange": "PNK", "regularMarketChangePercent": 0.81343734, "shortName": "Metacrine, Inc.", "longName": "Metacrine, Inc.", "firstTradeDateMilliseconds": 1600263000000, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-16", "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "displayName": "Metacrine", "symbol": "MTCR"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3985 Sorrento Valley Boulevard", "address2": "Suite C", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 369 7800", "fax": "858 369 7825", "website": "https://www.metacrine.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. David M. Maggio", "age": 63, "title": "Chief Bus. Officer, Pres, CEO, Sec., Treasurer, Principal Financial & Acct. Officer", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Patricia  Millican", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Theresa  Lowry", "age": 48, "title": "VP of HR", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}